CLRB
CLRB
NASDAQ · Biotechnology

Cellectar Biosciences Inc

$1.17
+0.01 (+0.86%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +3,428.2% upside
Low Target $32.58
Average Target $41.28
High Target $58.47
Current Price $1.17
Current
$1.17
Target
$41.28
$32.58 $41.28 avg $58.47
Scenario Analysis
Bear Case
$32.58
2,684.6%
Low target
Base Case
$41.28
+3,428.2%
Avg target
Bull Case
$58.47
+4,897.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$4.70
-75.1% from high
52-Week Low
$1.11
+5.4% from low
Target vs 52W High
$41.28
+778.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%